Sari Hopson

432 total citations
19 papers, 319 citations indexed

About

Sari Hopson is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Sari Hopson has authored 19 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Sari Hopson's work include Medication Adherence and Compliance (4 papers), Chronic Disease Management Strategies (3 papers) and Dialysis and Renal Disease Management (3 papers). Sari Hopson is often cited by papers focused on Medication Adherence and Compliance (4 papers), Chronic Disease Management Strategies (3 papers) and Dialysis and Renal Disease Management (3 papers). Sari Hopson collaborates with scholars based in United States, Netherlands and Sweden. Sari Hopson's co-authors include Diane L. Frankenfield, Michael V. Rocco, William McClellan, William M. McClellan, Haimanot Wasse, Andrew Renda, Amol D. Dhamane, Shuchita Kaila, Phil Schwab and Chad Moretz and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and American Journal of Kidney Diseases.

In The Last Decade

Sari Hopson

17 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sari Hopson United States	8	121	118	71	71	45	19	319
Monica Beaulieu Canada	13	100 0.8×	416 3.5×	65 0.9×	69 1.0×	71 1.6×	26	648
Nicholas Fluck United Kingdom	11	100 0.8×	225 1.9×	43 0.6×	44 0.6×	35 0.8×	20	429
Marc A G J ten Dam Netherlands	11	58 0.5×	230 1.9×	47 0.7×	13 0.2×	73 1.6×	24	484
Richard Phoon Australia	12	83 0.7×	282 2.4×	33 0.5×	9 0.1×	82 1.8×	27	610
Yena Jeon South Korea	11	49 0.4×	176 1.5×	32 0.5×	17 0.2×	26 0.6×	41	383
Gurprataap Singh Sandhu United States	15	125 1.0×	105 0.9×	30 0.4×	51 0.7×	51 1.1×	24	514
Karin Sennfält Sweden	13	95 0.8×	86 0.7×	123 1.7×	21 0.3×	40 0.9×	30	473
H.S. Wong Malaysia	11	32 0.3×	239 2.0×	73 1.0×	30 0.4×	39 0.9×	43	484
Seema Sondhi United Kingdom	11	177 1.5×	106 0.9×	86 1.2×	29 0.4×	45 1.0×	12	407
Ann C. McClellan United States	10	30 0.2×	120 1.0×	80 1.1×	27 0.4×	59 1.3×	11	372

Countries citing papers authored by Sari Hopson

Since Specialization

Citations

This map shows the geographic impact of Sari Hopson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sari Hopson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sari Hopson more than expected).

Fields of papers citing papers by Sari Hopson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sari Hopson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sari Hopson. The network helps show where Sari Hopson may publish in the future.

Co-authorship network of co-authors of Sari Hopson

This figure shows the co-authorship network connecting the top 25 collaborators of Sari Hopson. A scholar is included among the top collaborators of Sari Hopson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sari Hopson. Sari Hopson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Naidoo, Jarushka, Douglas B. Johnson, Yuexi Wang, et al.. (2024). Management of severe immune-related adverse events and outcomes in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors. The Oncologist. 30(8).

Hopson, Sari, et al.. (2023). Treatment Patterns and Healthcare Resource Utilization Among Newly Diagnosed Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis, and Hidradenitis Suppurativa Patients with Past Diagnosis of an Inflammatory Condition: A Retrospective Cohort Analysis of Claims Data in the United States. Advances in Therapy. 40(10). 4358–4376. 2 indexed citations

Huntington, Scott F., et al.. (2022). Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis. Journal of health economics and outcomes research. 9(2). 115–122. 5 indexed citations

Huntington, Scott F., et al.. (2022). Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis. Journal of health economics and outcomes research. 115–122. 5 indexed citations

Hopson, Sari. (2020). COPD exacerbation costs in the IMPACT study: a within-trial analysis. The American Journal of Managed Care. 26(5). e150–e154. 5 indexed citations

Shiozawa, Aki, et al.. (2020). Increased Healthcare Resource Utilization and Direct and Indirect Costs in Patients with Depression and Comorbid Overactive Bladder: Evidence From a Retrospective, Matched Case–Control Cohort Analysis. Advances in Therapy. 37(11). 4599–4613. 3 indexed citations

Williamson, Todd, et al.. (2020). Rosacea Treatment Satisfaction: Matching Adjusted Indirect Treatment Comparison Analysis of Metronidazole Gel or Cream vs Azelaic Acid Foam. Journal of Drugs in Dermatology. 19(3). 295–304. 1 indexed citations

Hopson, Sari, Andrew Renda, Aparna R. Parikh, et al.. (2019). Using the Healthy Days Measure to Assess Factors Associated with Poor Health-Related Quality of Life for Patients with Metastatic Breast, Lung, or Colorectal Cancer Enrolled in a Medicare Advantage Health Plan. Population Health Management. 22(5). 440–448. 7 indexed citations

Bogart, Michael, et al.. (2019). Exacerbation Costs Associated with FF/UMEC/VI Therapy in COPD Compared with FF/VI and UMEC/VI Therapy. A7034–A7034.

10.

Michael, Todd P., Andrew Renda, Sari Hopson, et al.. (2018). The relationship between comorbidity medication adherence and health related quality of life among patients with cancer. Journal of Patient-Reported Outcomes. 2(1). 29–29. 21 indexed citations

11.

Hopson, Sari, et al.. (2018). The Relationship Between Guideline-Recommended Initiation of Therapy, Outcomes, and Cost for Patients with Metastatic Non-Small Cell Lung Cancer. Journal of Managed Care & Specialty Pharmacy. 24(6). 554–564. 4 indexed citations

12.

Schwab, Phil, Amol D. Dhamane, Sari Hopson, et al.. (2017). Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population. International Journal of COPD. Volume 12. 735–744. 46 indexed citations

13.

Hopson, Sari, et al.. (2017). Does site-of-care for oncology infusion therapy influence treatment patterns, cost, and quality in the United States?. Journal of Medical Economics. 21(2). 152–162. 6 indexed citations

14.

Dhamane, Amol D., Phil Schwab, Sari Hopson, et al.. (2016). Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients. International Journal of COPD. Volume 12. 115–122. 30 indexed citations

15.

Hopson, Sari, Kim Saverno, Larry Z. Liu, et al.. (2016). Impact of Out-of-Pocket Costs on Prescription Fills Among New Initiators of Biologic Therapies for Rheumatoid Arthritis. Journal of Managed Care & Specialty Pharmacy. 22(2). 122–130. 31 indexed citations

16.

Hopson, Sari, et al.. (2016). Is there a relationship between self-reported healthy days and comorbidity medication adherence among oncology patients?. Journal of Clinical Oncology. 34(7_suppl). 189–189. 2 indexed citations

17.

Wasse, Haimanot, Sari Hopson, & William McClellan. (2010). Racial and Gender Differences in Arteriovenous Fistula Use among Incident Hemodialysis Patients. American Journal of Nephrology. 32(3). 234–241. 37 indexed citations

18.

Hopson, Sari, Diane L. Frankenfield, Michael V. Rocco, & William McClellan. (2008). Variability in Reasons for Hemodialysis Catheter Use by Race, Sex, and Geography: Findings From the ESRD Clinical Performance Measures Project. American Journal of Kidney Diseases. 52(4). 753–760. 36 indexed citations

19.

Rocco, Michael V., Diane L. Frankenfield, Sari Hopson, & William M. McClellan. (2006). Relationship between Clinical Performance Measures and Outcomes among Patients Receiving Long-Term Hemodialysis. Annals of Internal Medicine. 145(7). 512–519. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact